Purpose: The pharmacology, pharmacokinetics, drug interactions, clinical efficacy, adverse effects, monitoring, and dosage and administration of enteric-coated (EC) mycophenolate sodium are reviewed.
Vaccination by homologous antigenic loading with DOC1021 as adjuvant therapy for glioblastoma: Phase I clinical trial results. Use of lucicebtide (ST101) in glioblastoma patients by antagonism of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results